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The Saudi Journal of Gastroenterology to be more stressful to patients when preceded by the colonoscopy. [13, 14] The increase in the discomfort during the EGD examination when performed after the colonoscopy was also reported by another study abstract in subjects with moderate sedation. [15] When propofol-induced deep sedation was applied, lower propofol doses and better EGD tolerability were reported when the EGD was performed before the colonoscopy. [16] Nevertheless, a recent study demonstrated that there were no differences in the patients' discomfort and satisfaction regarding the procedure sequence. [17] Because carbon dioxide (CO 2 ) is absorbed across the intestines 160 times more rapidly than nitrogen and 13 times more rapidly than oxygen, which are the principal gas components of air, [18] CO 2 insufflation has been commonly used in modern colonoscopies to decrease abdominal discomfort during and following the procedure. [19] [20] [21] [22] The aforementioned side effect of gas insufflation during EGD-colonoscopy sequence might be negligible when CO 2 insufflation is used. A same-day BDE study using CO 2 insufflation has not been reported in the literature. Therefore, we conducted a paired comparison analysis using moderate sedation and CO 2 insufflation on the procedural sequence of the same-day BDE.
The primary aim of this study was to compare the sedative doses and patient discomfort between the study groups who received a colonoscopy followed by an EGD (colonoscopy-EGD) or an EGD followed by a colonoscopy (EGD-colonoscopy) during a same-day BDE. The secondary aim was to assess colonoscopy performance, including the cecal intubation time and polyp detection rate between the two endoscopic sequences.
PATIENTS AND METHODS

Patients
This was a prospective, observational study conducted from August 2013 to August 2015 at the Evergreen General Hospital, Taiwan. Asymptomatic patients admitted to our physical check-up department for a same-day BDE examination within 2 consecutive years were enrolled. During BDE scheduling, patients provided: (1) a personal history of major comorbid diseases, (2) a past history of abdominal surgeries, and (3) a current medication list. Patient demographics and BDE findings were prospectively collected and stored in a central database. Patients with the following conditions were excluded: Previous gastrectomy or colectomy, inadequate bowel preparation, hot snare polypectomy for gastric or colon polyp, obstructive lesions of the colon, severe colitis, gastrointestinal bleeding, allergy to fentanyl or midazolam, American Society of Anesthesiology (ASA) classification of physical status grade 3 or higher, age < 18 years, and refusal to provide a written informed consent. The study was approved by the Institutional Review Board of Evergreen General Hospital.
Endoscopy procedures
Patients enrolled in this study underwent a BDE with the colonoscopy-EGD sequence in the first year of check-up and a BDE with the EGD-colonoscopy sequence in the second year of check-up. All BDE examinations were performed under moderate conscious sedation with fentanyl (United Biomedical; Taipei, Taiwan) and midazolam (Dormicum; Roche Pharmaceuticals, Basel, Switzerland) according to the current guidelines. [23, 24] Moderate sedation was provided by gastroenterologists. CO 2 insufflation was used for all endoscopic procedures. Endoscopies were performed by two experienced endoscopists (CL Cheng, YL Kuo) who conducted more than 500 examinations annually. BDE examinations were performed with a standard upper endoscopy (GIF-Q260; Olympus Medical Systems Corp., Tokyo, Japan) and colonoscopy (CF-Q260AI or CF-Q260AL; Olympus Medical Systems Corp., Tokyo, Japan). All patients received 3-L polyethylene glycol (PEG; Klean-Prep, Helsinn Birex Pharmaceuticals Ltd., Dublin, Ireland) for bowel preparation. A split-dose of the PEG preparation was provided for morning colonoscopy (2 L consumed in the evening before the colonoscopy and 1 L consumed in the early morning of the colonoscopy) and a same-day preparation was provided for the afternoon colonoscopy. The level of colon cleansing was prospectively scored at the time of the colonoscopy with the Boston Bowel Preparation Scale (BBPS). In this study, an excellent bowel preparation was defined as a total BBPS score of 8 or higher, a good preparation as a total score of 7, a fair preparation as a total score of 6, and a poor preparation as a total score of 5 or less. Cecal intubation time was defined as the time between the scope insertion and cecal intubation. Colonoscopy withdrawal time was defined as the duration between the time at which the cecum was reached and the time at which the scope was withdrawn from the anus.
A procedure score was used to define the complexity of the endoscopic procedures: Diagnostic procedure (score 0) and interventional procedure (score 1). Total procedure score ranged from 0 to 2 in each BDE examination. Interventional procedures included biopsy removal of polyps, biopsy histology for peptic ulcer/erosion, and a biopsy for colitis. Rapid urease test during the EGD examination was considered a diagnostic procedure.
Blood pressure, heart rate, and oxygen saturation were monitored and recorded during the endoscopic procedures. Supplemental oxygen by nasal cannula was provided when oxygen desaturation was detected by pulse oximetry. The duration of EGD and colonoscopy examinations, cecal intubation time, procedure complexity, and total sedative doses were recorded by a gastroenterology nurse after each BDE examination. The following adverse events were recorded during conscious sedation: (1) oxygen desaturation:
The Saudi Journal of Gastroenterology <90% persisting for more than 30 s; (2) hypotension: <90 mmHg systolic blood pressure for more than 30 s; (3) hypertension: >180 mmHg systolic blood pressure for more than 30 s; (4) tachycardia: >120 beats per minute, lasting more than 30 s; and (5) bradycardia: <50 beats per minute, lasting more than 30 s.
Recovery time from moderate sedation was assessed at 15 and 25 min after the BDE examination using the Aldrete scale. [25] The time interval between arrival at the recovery room and the time of discharge was recorded.
Evaluation of patient discomfort
The grade of the patient's discomfort, as perceived by the endoscopist, was rated after every endoscopy using a 10-point Likert scale: 0, no discomfort at all; 5, need for multiple additions of sedative agents during the procedure; and 10, abortion of the procedure because of the patient's agitation. After recovery, patients were asked to fill a standard questionnaire using a 10-cm visual scale to report the extent of discomfort.
Statistical analysis
The primary aim of the study was to evaluate whether there was a difference in the total dose of sedative agents between the two groups. Power calculation estimated that 60 patients in each group would ensure 90% power of detecting a mean of paired difference of 0.6 mg in the dose of midazolam (given a standard deviation of 1.4 mg) or 5.5 μg in the dose of fentanyl (given a standard deviation of 12 μg) with a two-sided significance of 5%. Summary statistics were presented as percentages in the case of categorical variables and as the means with standard deviations in the case of continuous variables. The paired t-test for continuous data and the McNemar test for binary data were used to compare the differences between the two study groups. All calculations were conducted using SAS version 9.3 software (SAS Institute Inc., Cary, NC, USA). The criterion for statistical significance was P < 0.05.
RESULTS
A total of 75 patients were enrolled in the study and 12 patients were excluded (six patients had inadequate preparation and six patients underwent a polypectomy during the BDE procedure). The 63 patients eligible for analysis underwent the colonoscopy-EGD sequence during the first BDE examination and the EGD-colonoscopy sequence during the second BDE examination. The mean duration between the two BDE examinations was 15 months (range: 12-18 months). There were no significant differences between the two study groups regarding age, body weight, body mass index, ASA classification status, or history of abdominal surgery [ Table 1 ]. Table 2 shows the endoscopy and sedation related parameters between the two study groups. The durations required to complete the EGD, colonoscopy, and BDE procedures were similar between the two study groups. The total procedure score was comparable between the two study groups. The total dose of fentanyl was significantly higher in the colonoscopy-EGD group than that in the EGD-colonoscopy group (70.8 ± 9.6 μg vs. 56.6 ± 9.2 μg, P < 0.0001, respectively). In addition, the total dose of midazolam was significantly higher in the colonoscopy-EGD group than that in the EGD-colonoscopy group (6.1 ± 1.3 mg vs. 4.6 ± 1.1 mg, P < 0.0001, respectively). Correspondingly, the post-procedure recovery evaluation regarding 15-min Aldrete score revealed a significantly lower score in the colonoscopy-EGD group than that in the EGD-colonoscopy group (9.1 ± 0.7 vs. 9.5 ± 1.3, P = 0.037, respectively), and the recovery time for patient discharge was significantly longer in the colonoscopy-EGD group than that in the The Saudi Journal of Gastroenterology EGD-colonoscopy group (38.5 ± 3.9 min vs. 31.9 ± 3.2 min, P < 0.0001, respectively). There was no significant difference in the post-procedural recovery evaluations regarding the 25-min Aldrete score between the two study groups. Table 3 shows the questionnaire results of patient discomfort during the BDE examination. Subjective discomfort with the EGD examination, as assessed by both the patient and endoscopist, was significantly higher in the colonoscopy-EGD group than that in the EGD-colonoscopy group. Subjective discomfort with colonoscopy examination, as assessed by both the patient and endoscopist, was similar between the two groups. Table 4 summarizes the colonoscopy quality between the two study groups. Cecal intubation was achieved in all patients. The BBPS score, patients with excellent/good preparation, cecal intubation time, and colonoscopy withdrawal time were similar between the two study groups. No significant difference of polyp detection was found between the two study groups. However, more adenomas were detected in the colonoscopy-EGD group than that in the EGD-colonoscopy group (73% vs. 54%, P = 0.023, respectively). Table 5 shows the adverse events related to conscious sedation in the study population. Similar proportions of patients in the two study groups experienced hypoxemia, hypertension, hypotension, and tachycardia. All these episodes were transient, did not necessitate termination of the examination, and were followed by a full recovery of the patients. Bradycardia did not occur in any patient.
DISCUSSION
In this prospective, paired comparison study, we found that patients required a lower total dose of fentanyl and midazolam and a shorter recovery time when the EGD-colonoscopy sequence was used in the BDE examination. We also found that the EGD was better tolerated by patients when it was performed first. The total duration of procedures, the complexity of endoscopic procedures, and sedation-related adverse events did not differ significantly between the EGD-colonoscopy and the colonoscopy-EGD groups. To the best of our knowledge, this is the first study of patients undergoing a same-day BDE under moderate sedation with a fentanyl/midazolam combination and gas insufflations with CO 2 .
In our study, the mean total doses of moderate sedation with fentanyl and midazolam were significantly higher in the colonoscopy-EGD group than that in the EGD-colonoscopy group (P < 0.0001 and P < 0.0001, respectively). The finding was in agreement with a previous study using deep sedation with propofol. Hsieh et al. [16] reported that lower propofol 
EGD-colonoscopy BDE (n=63)
P-value
EGD: Esophagogastroduodenoscopy, BDE: Bidirectional endoscopy, NS: Not significant doses were needed when a same-day BDE was started with the EGD (124 mg vs. 135 mg, P = 0.024, respectively). However, in another same-day BDE study using moderate sedation with meperidine/midazolam, Carter et al. [17] found that there was no significant difference in the total doses of additional midazolam between the colonoscopy-EGD and The Saudi Journal of Gastroenterology the EGD-colonoscopy groups (1.41 vs. 1.14 mg, P = 0.67, respectively). In the study, meperidine 50 mg and midazolam 2.5 mg were provided for every patient in both BDE groups during the initial preparation phase, and the authors did not analyze the difference of total meperidine and midazolam doses between the two study groups. The advantage of the EGD-colonoscopy sequence in our study could be explained by the endoscopy nature and the pharmacologic profile of drugs used for endoscopic sedation. In the current study, the average durations of the EGD and colonoscopy examinations were approximately 5.5 and 23 min, respectively. After intravenous administration, the onset of effect of fentanyl is 1-2 min, the peak effect is achieved within 3-5 min, and the duration of effect is 30-60 min. [23] After intravenous administration, the onset of midazolam's effect is 1-2 min, the peak effect is achieved within 3-4 min, and the duration of its effect is 15-80 min. [23] In patients undergoing the EGD-colonoscopy sequence of the BDE examination, the sedative agents posed their peak effect when the EGD was completed, and they remained pharmacologically effective during most of the colonoscopy. Accordingly, only small doses of sedative agents were needed during the colonoscopy examination. However, in patients undergoing colonoscopy-EGD sequence, the effect of sedative agents had already waned when the colonoscopy was completed, and thus, more doses were needed for the upcoming EGD examination.
The smaller doses of total sedative agents are rationally related to a shorter recovery time. In our study, the average recovery time for patient discharge was significantly shorter for the EGD-colonoscopy group compared to the colonoscopy-EGD group (31.9 min vs. 38.5 min, P < 0.0001, respectively). However, the finding was different from a previous report in which propofol was used for deep sedation. Hsieh et al. [16] demonstrated that a lower overall dose of propofol was required for patients with EGD-colonoscopy sequence, but the recovery time to leaving did not differ between the EGD-first and the colonoscopy-first groups (15.2 min vs. 15.3 min, P = 0.954, respectively). The reason for such a discrepancy could be explained by the pharmacologic profile between propofol and fentanyl/midazolam. Propofol is highly lipid soluble and has an onset of action equivalent to one arm-brain circulation (i.e., 30-45 s). [23] Propofol is metabolized rapidly in the liver with peak effect achieved within 1-2 min and duration of effect of 4-8 min. Because of its short half-life of action, patients receiving propofol could be discharged at an earlier time. It is likely that the benefit of lower propofol dose was offset by its short-acting pharmacologic profile.
In same-day BDE, gas insufflation during the first procedure may affect the examination of the second procedure. Cho et al. [13] found that the quality of the EGD was influenced by the sequence of the procedures. Moreover, some endoscopists believed that gas insufflation during EGD may make a subsequent colonoscopy more difficult. With the introduction of CO 2 insufflation, the aforementioned negative influence of gas insufflation during the first endoscopic procedure could be minimized. In our study, we found that the colonoscopy quality, including cecal intubation rate, cecal intubation time, and polyp detection rate, were similar regardless of which examination was performed first [ Table 4 ]. The colon adenoma detection rate being significantly lower in the EGD-colonoscopy group than in the colonoscopy-EGD group could be explained by our study design. The EGD-colonoscopy sequence of the BDE was performed an average of 18 months after the colonoscopy-EGD sequence, and thus, the colon adenomas were theoretically fewer than the first BDE study.
Similar to the results of previous studies, analysis of patient and endoscopist questionnaires revealed that patients experienced greater subjective discomfort with the EGD when they underwent the colonoscopy-EGD sequence compared to the EGD-colonoscopy sequence. [13, 14] Poor tolerance to esophageal intubation and inadequate sedation were two major reasons for such discomfort. In both the colonoscopy-EGD and EGD-colonoscopy groups, most doses of midazolam were provided during the first examination (64 and 80%, respectively). In the colonoscopy-EGD group, the mean dose of midazolam provided in the colonoscopy study was 3.9 mg and the mean dose of midazolam added in the EGD study was 2.2 mg. Because of the long procedure time of the colonoscopy, midazolam's effect had started to wane when EGD was performed. However, the maximum dose of midazolam for endoscopic sedation is approximately 6 mg, based on guideline suggestions, which limits the addition of a midazolam dose during the EGD examination. [22, 23] In the EGD-colonoscopy group, the mean dose of midazolam provided in the EGD study was 3.7 mg and the mean dose of midazolam added in the colonoscopy was 0.9 mg. With adequate sedation during the EGD examination and less midazolam needed in the colonoscopy examination, patients in the EGD-colonoscopy group had lower sedative doses and a shorter recovery time.
A major strength of our study is that we provided CO 2 insufflation during BDE examination, which has not been reported in previous studies. Another strength is the paired comparison study design in which each patient is used as his/her own control, and thus, the individual differences became irrelevant. A major limitation is that it is designed as one sequence (i.e., colonoscopy-EGD followed by EGD-colonoscopy), rather than a crossover study design, and therefore, the period effect cannot be evaluated. Another limitation is the lack of patient randomization. Selection bias and decreased comparability between groups may have Volume 22, Number 5
The Saudi Journal of Gastroenterology occurred. Another limitation was that the physician was not blind to the sequence of the endoscopic procedures. Moreover, the procedures were performed by experienced endoscopists, so the results may vary for less experienced endoscopists.
CONCLUSION
Our study demonstrated that the EGD-colonoscopy sequence is the best choice for a same-day BDE with moderate sedation and CO 2 insufflation. Patients with the EGD-colonoscopy sequence tolerated the procedures better, needed less sedative doses, and had a shorter recovery time. The sequence of BDE procedures did not affect the colonoscopy quality. Further prospective, randomized controlled studies are warranted to confirm our observational study results.
